CSURGSU.BO stock opened weaker in pre-market trading on 17 Mar 2026 after a sharp decline of -18.00% to INR 87.73. The move followed heavy early selling from an intraday high of INR 106.70, with volume at 574 versus an average of 194, signaling outsized participation. Investors should note Centenial Surgical Suture Limited (CSURGSU.BO) trades on the BSE in India and shows a stretched technical setup between the 50-day average of INR 95.26 and the 200-day average of INR 117.18. We analyse why the stock sits among pre-market top losers and what analysts and models imply next.
Price action and immediate triggers for CSURGSU.BO stock
The most immediate fact is a one-day fall of INR 19.26 or -18.00% to INR 87.73 in pre-market on 17 Mar 2026. Trading opened at INR 106.70 before intraday selling pushed price to a low of INR 87.30. Volume of 574 shares was nearly 2.96x the average, showing aggressive selling interest. There is no single public corporate announcement today; the drop appears driven by profit-taking and a faster-than-normal sell flow versus the stock’s average liquidity.
Fundamentals and valuation snapshot for CSURGSU.BO stock
Centenial Surgical Suture Limited reports trailing EPS of -2.95 and a trailing PE of -29.74, reflecting recent losses. Price-to-book is 1.04 and price-to-sales is 0.59, while the market cap stands at INR 320,065,359.00. The company has a current ratio of 2.03 and debt-to-equity of 0.35, which point to manageable short-term liquidity and moderate leverage. Key weaknesses include negative ROE of -3.47% and long inventory days of 583.08, which pressure working capital.
Technical signals and support levels for CSURGSU.BO stock
Technicals show RSI at 44.65, MACD histogram positive but momentum indicators weakening. Bollinger bands mid is INR 93.58 with a lower band at INR 78.47, suggesting price is within band support. Immediate support is the year low of INR 82.15 and psychological round levels near INR 80.00. Short-term resistance lies at the 50-day average INR 95.26 and then the 200-day average INR 117.18. Traders should watch the ATR 6.70 for daily risk sizing.
Meyka AI rates CSURGSU.BO stock with a score out of 100 and technical analysis
Meyka AI rates CSURGSU.BO with a score out of 100: 67.58 / 100 (Grade B, Suggestion: HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Technical indicators show mixed momentum, with an ADX of 20.71 indicating a non-dominant trend. Note this grade is informational and not financial advice.
Sector context and how Healthcare trends affect CSURGSU.BO stock
Centenial operates in Healthcare, Medical – Specialties, where the sector average PE is 37.12 and YTD sector performance is down -8.01%. Smaller medical-device names often face higher volatility when funding or working capital metrics change. Centenial’s inventory days and receivables cycle make it sensitive to demand shifts in surgical consumables and export flows. Investors should compare CSURGSU.BO performance to peers before repositioning.
Risks, catalysts and analyst focus for CSURGSU.BO stock
Key risks: negative trailing EPS (-2.95), thin liquidity (avg volume 194) and stretched inventory days (583.08). Catalysts that could reverse the decline include an earnings beat, margin recovery, or clearer working capital improvement. Analysts will watch the next earnings update (last announced in 2025) and export orders. Given low free-cash-flow yield and tight cash per share INR 1.53, any sign of cash flow improvement would be material.
Final Thoughts
CSURGSU.BO stock sits among pre-market top losers on 17 Mar 2026 after an 18.00% decline to INR 87.73 on higher-than-normal volume. Fundamentals show a mixed picture: manageable leverage (debt/equity 0.35) and current ratio 2.03, offset by negative EPS (-2.95) and long inventory days (583.08). Meyka AI’s forecast model projects a 1-year target of INR 132.51, implying an implied upside of 51.05% versus the current price of INR 87.73; monthly and quarterly model points sit at INR 96.49 (+10.00%) and INR 78.58 (-10.43%) respectively. Forecasts are model-based projections and not guarantees. Short-term traders should respect support at INR 82.15 and size positions to the ATR 6.70. Longer-term investors should wait for clearer cash-flow recovery or earnings improvement before adding material exposure. Meyka AI provides this analysis as an AI-powered market analysis platform to help frame risk and opportunity, but this is not investment advice.
FAQs
Why did CSURGSU.BO stock fall pre-market on 17 Mar 2026?
CSURGSU.BO stock fell about 18.00% primarily on heavy selling and above-average volume (574 vs avg 194). No single public corporate release explains the move; traders pointed to profit-taking and liquidity-driven pressure in a thinly traded stock.
What are the key valuation metrics for CSURGSU.BO stock?
Centenial shows EPS -2.95, PE -29.74, PB 1.04, price-to-sales 0.59, and market cap INR 320,065,359.00. These signal low market pricing versus book but negative earnings and weak cash flow trends.
What is Meyka AI’s short-term forecast for CSURGSU.BO stock?
Meyka AI’s forecast model projects a monthly target of INR 96.49, a quarterly target of INR 78.58, and a 1-year target of INR 132.51. These are model outputs and not guarantees; trade sizing should match risk tolerance.
What support and resistance should traders watch for CSURGSU.BO stock?
Watch immediate support at the year low INR 82.15 and Bollinger lower at INR 78.47. Near-term resistance is the 50-day average INR 95.26 and the 200-day average INR 117.18.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)